These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7298190)

  • 1. Experimental cholera in germfree suckling mice.
    Shimamura T; Tazume S; Hashimoto K; Sasaki S
    Infect Immun; 1981 Oct; 34(1):296-8. PubMed ID: 7298190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of gnotobiotic animals for the study of the pathogenesis of cholera intoxication].
    Isupov IV; Podoprigora GI; Dushkin VA; Gor'kova AV; Nazarova LS
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):44-8. PubMed ID: 2469271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a germfree mouse model of Vibrio cholerae infection.
    Butterton JR; Ryan ET; Shahin RA; Calderwood SB
    Infect Immun; 1996 Oct; 64(10):4373-7. PubMed ID: 8926115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against Vibrio cholerae El Tor infection by specific antibodies against mannose-binding hemagglutinin pili.
    Osek J; Svennerholm AM; Holmgren J
    Infect Immun; 1992 Nov; 60(11):4961-4. PubMed ID: 1356934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient Intestinal Colonization by a Live-Attenuated Oral Cholera Vaccine Induces Protective Immune Responses in Streptomycin-Treated Mice.
    Fakoya B; Sit B; Waldor MK
    J Bacteriol; 2020 Nov; 202(24):. PubMed ID: 32540930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selection of hypotoxigenic Vibrio cholerae population by human intestinal bacteria in gnotobiotic mice.
    Watanabe S; Shimamura T; Aiba Y; Ozawa A; Sasaki S
    Tokai J Exp Clin Med; 1986 Aug; 11(3):155-62. PubMed ID: 3617104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Model of a chronic Vibrio cholerae carrier based on gnotobiotic rats].
    Baroian OV; Chakava OV; Gaĭlonskaia IN; Abrikosova NIu; Blinova NI
    Biull Eksp Biol Med; 1976 May; 81(5):561-4. PubMed ID: 947380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. El Tor Biotype
    Mamantopoulos M; Frising UC; Asaoka T; van Loo G; Lamkanfi M; Wullaert A
    Front Immunol; 2019; 10():2463. PubMed ID: 31736941
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
    Tacket CO; Cohen MB; Wasserman SS; Losonsky G; Livio S; Kotloff K; Edelman R; Kaper JB; Cryz SJ; Giannella RA; Schiff G; Levine MM
    Infect Immun; 1999 Dec; 67(12):6341-5. PubMed ID: 10569747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.
    Guentzel MN; Berry LJ
    Infect Immun; 1974 Jul; 10(1):167-72. PubMed ID: 4601899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect on infections with Vibrio cholerae in suckling mice caused by the passive immunization with milk of immune mothers.
    Ujiye A; Kobari K
    J Infect Dis; 1970 May; 121():Suppl 121:50+. PubMed ID: 5463400
    [No Abstract]   [Full Text] [Related]  

  • 12. Passive oral immunization by egg yolk immunoglobulin (IgY) to Vibrio cholerae effectively prevents cholera.
    Hirai K; Arimitsu H; Umeda K; Yokota K; Shen L; Ayada K; Kodama Y; Tsuji T; Hirai Y; Oguma K
    Acta Med Okayama; 2010 Jun; 64(3):163-70. PubMed ID: 20596127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiological mechanisms of diarrhea caused by the Vibrio cholerae O1 El Tor variant: an in vivo study in mice.
    Satitsri S; Pongkorpsakol P; Srimanote P; Chatsudthipong V; Muanprasat C
    Virulence; 2016 Oct; 7(7):789-805. PubMed ID: 27222028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of normal microflora in the treatment of vibrio carrier state in rat gnotobionts].
    Baroian OV; Abrikosova NIu; Gaĭlonskaia IN; Chakhava OV; Blinova NI
    Biull Eksp Biol Med; 1978 Jun; 85(6):712-5. PubMed ID: 352437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antibodies against biotype-specific Vibrio cholerae pili in protection against experimental classical and El Tor cholera.
    Osek J; Jonson G; Svennerholm AM; Holmgren J
    Infect Immun; 1994 Jul; 62(7):2901-7. PubMed ID: 7911787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody against the capsule of Vibrio cholerae O139 protects against experimental challenge.
    Sengupta DK; Boesman-Finkelstein M; Finkelstein RA
    Infect Immun; 1996 Jan; 64(1):343-5. PubMed ID: 8557361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of Vibrio cholerae from nightsoil during epidemics of classical and E1 Tor Cholera in East Pakistan.
    Bart KJ; Khan M; Mosley WH
    Bull World Health Organ; 1970; 43(3):421-9. PubMed ID: 5312997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Morphological study of the effect of cholera toxin on germ-free animals].
    Isupov IV; Nazarova LS; Pavlova LP; Go'kova AV; Podoprigora GI
    Arkh Patol; 1981; 43(5):36-41. PubMed ID: 7283785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of Vibrio cholerae O1 biotype El Tor serotype Inaba causing outbreaks of cholera in Orissa, India.
    Pal BB; Khuntia HK; Samal SK; Das SS; Chhotray GP
    Jpn J Infect Dis; 2006 Aug; 59(4):266-9. PubMed ID: 16936349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.